Celon Pharma Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,139	1,425	789	716	1,691	1,825
Market Cap Growth	-22.95%	80.47%	10.32%	-57.68%	-7.35%	2.14%
Enterprise Value	1,132	1,336	704	578	1,487	1,807
Last Close Price	21.15	26.45	15.38	13.87	32.20	39.31
Forward PE	-	35.84	-	-	-	51.01
PS Ratio	5.05	6.93	3.68	3.69	8.62	11.59
PB Ratio	2.93	3.20	1.77	1.49	3.05	5.30
P/TBV Ratio	2.95	3.26	1.83	1.56	3.21	5.96
P/FCF Ratio	-	-	-	-	650.25	-
P/OCF Ratio	2408.17	-	-	-	38.47	25.44
EV/Sales Ratio	5.02	6.50	3.28	2.98	7.59	11.48
EV/EBITDA Ratio	-	-	81.54	-	53.42	70.90
EV/FCF Ratio	-27.46	-	-	-	572.04	-
Debt / Equity Ratio	0.04	0.04	0.06	0.06	0.03	0.07
Debt / EBITDA Ratio	-	-	1.24	5.92	0.52	1.00
Debt / FCF Ratio	-	-	-	-	5.74	-
Net Debt / Equity Ratio	-0.02	-0.13	-0.20	-0.29	-0.38	-0.05
Net Debt / EBITDA Ratio	0.08	3.88	-10.30	53.60	-7.64	-0.73
Net Debt / FCF Ratio	0.17	1.70	2.16	3.57	-81.78	0.67
Asset Turnover	0.41	0.37	0.35	0.29	0.32	0.28
Inventory Turnover	2.82	2.23	2.06	2.15	2.32	1.23
Quick Ratio	1.38	1.90	1.89	1.70	2.95	0.75
Current Ratio	1.90	2.40	2.20	2.04	3.23	1.05
Return on Equity (ROE)	-27.03%	-7.73%	-6.08%	-7.60%	-2.58%	-0.23%
Return on Assets (ROA)	-12.83%	-5.94%	-2.92%	-3.51%	-1.07%	-0.46%
Return on Invested Capital (ROIC)	-29.93%	-14.24%	-8.12%	-11.09%	-3.17%	-1.16%
Return on Capital Employed (ROCE)	-26.90%	-11.10%	-5.90%	-7.20%	-1.70%	-1.00%
Earnings Yield	-10.74%	-2.42%	-3.56%	-5.49%	-0.69%	-0.05%
FCF Yield	-3.62%	-2.40%	-5.21%	-5.40%	0.15%	-1.52%
Dividend Yield	-	-	0.52%	0.65%	0.90%	0.18%
Buyback Yield / Dilution	1.95%	-2.86%	-0.04%	-9.32%	-3.74%	-
Total Shareholder Return	1.95%	-2.86%	0.48%	-8.67%	-2.84%	0.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.